Printer Friendly

NITROSTAT SUPPLIES REPLENISHED

 WASHINGTON, Jan. 8 /PRNewswire/ -- The Food and Drug Administration has been receiving inquiries expressing concern about the supply of Parke-Davis & Co.'s Nitrostat, a nitroglycerin tablet that is dissolved under the tongue for treatment of acute angina. Warner-Lambert, which owns Parke-Davis, has reported that problems with new manufacturing processes for the drug may have temporarily disrupted distribution of the drug in certain strengths to some outlets.
 Although spot shortages have occurred, the company is quickly resupplying pharmacies, and no public health problems are anticipated. According to reports the agency has received, production problems with this product have been resolved, and full distribution has now resumed.
 The company has released an additional 300,000 bottles of Nitrostat in the 0.3 and 0.4 milligram strengths, which should take care of any backlogs and provide an adequate supply of the drug throughout the country by Tuesday, Jan. 12. Warner-Lambert has informed doctors and pharmacists of the status of the distribution and is sending an additional letter to pharmacists today with more details. The company is shipping the product by air freight to its distributors, and has established a mechanism to ensure availability to all pharmacies.
 In the meantime, patients should obtain the drug in normal quantities only, to ensure adequate supplies for all. Pharmacists should use prudence in filling large requests. Substitution of lower-strength tablets may be made in some cases where higher- strength tablets are unavailable. Patients with questions about this matter should consult their physician or pharmacist.
 -0- 1/8/93
 /NOTE: TV Broadcasters please use open caption for the hearing impaired./
 /CONTACT: Susan Cruzan of the Food and Drug Administration, 301-443-4177 or, after hours, 301-926-7081/


CO: Food and Drug Administration ST: District of Columbia IN: MTC SU:

KD -- DC015 -- 3110 01/08/93 15:08 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 8, 1993
Words:298
Previous Article:NATIONWIDE SUBSIDIARY VOWS VIGOROUS FIGHT AGAINST "GROUNDLESS" ALLEGATIONS
Next Article:BIG THREE CEO'S AND UAW PRESIDENT COMMENT ON MEETING WITH MICHIGAN CONGRESSIONAL DELEGATION
Topics:


Related Articles
KV Pharmaceutical Introduces New Nitroglycerin Sublingual Product.
Weighing/dispensing system. (Equipment).
QUICK MARCH; Left..left..left..left.
Emergency Weekend Blood Drives Scheduled to Help Regional Shortage Caused By Power Blackout.
The Spinx Company Commits to Operate at a Zero Profit Margin on All Gasoline Sales and Merchandise Sales in Response to Hurricane Disaster.
Blood squad.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters